CDKN2A and glioma: Some of the reported limitations in the above studies include false positive FISH results due to partial hybridization failure, artifacts, and sub-optimal p16 cutoff values, hampering the standardized use of p16 as a surrogate marker for CDKN2A homozygous deletion in gliomas.